Recent News

• 09.04.2025 - Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 08.27.2025 - Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash
• 08.27.2025 - Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash
• 08.11.2025 - Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates
• 08.11.2025 - Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates
• 08.11.2025 - Azitra, Inc. Announces Reverse Stock Split
• 08.11.2025 - Azitra, Inc. Announces Reverse Stock Split

Recent Filings

• 08.29.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 08.29.2025 - 8-K Current report
• 08.20.2025 - 8-K Current report
• 08.20.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 8-K Current report
• 08.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.24.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 07.23.2025 - EFFECT Notice of Effectiveness